Sarcoma  >>  TAEST16001  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TAEST16001 / Guangzhou Xiangxue Pharma, Athenex
NCT05549921: Phase II Study of TAEST16001 in Soft Tissue Sarcoma

Recruiting
2
70
RoW
NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)
Sun Yat-sen University, Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Soft Tissue Sarcoma
09/24
09/24

Download Options